mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-07 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-07 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |